
Mustang Bio, Inc.
MBIOHealthcare|Biotechnology|US
$0.39
+0.00 (+0.15%)
DCF Value
$2.93
Tangible Book / Share
$0.98
Cash / Share
$2.12
Ownership Breakdown
95.7%
Float
6.7M
Shares Outstanding
6.4M
Float Shares
Major Holders (6)
Combined: 33.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. | HC, CO | 8.00% | 537,243 | Jan 5, 2026 | 13D/G |
| Daniel B. Asher | HC, IN | 4.99% | 185,527 | Aug 12, 2025 | 13D/G |
| Mitchell P. Kopin | HC, IN | 4.99% | 185,527 | Aug 12, 2025 | 13D/G |
| Intracoastal Capital LLC | Other | 4.99% | 185,527 | Aug 12, 2025 | 13D/G |
| Steven Boyd | HC, IN | 4.99% | 129,213 | May 15, 2025 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.99% | 129,213 | May 15, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 127,387 acquired · 278 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Litchman Manuel MD | director, officer: President, CEO and Interim CFO | Apr 24, 2026 | TAX W/H | 19 | $0.75 | $14.25 | Form 4 |
| Fortress Biotech, Inc. | 10 percent owner | Jan 2, 2026 | AWARD | 278,385 | — | — | Form 4 |
| Herskowitz Neil | director | Dec 30, 2025 | SELL | 247 | $0.96 | $237.61 | Form 4 |
| Chill Adam J. | director | Dec 30, 2025 | SELL | 4 | $0.95 | $3.82 | Form 4 |
| Jin David | director | Dec 30, 2025 | BUY | 247 | $0.96 | $237.61 | Form 4 |
| Fortress Biotech, Inc. | 10 percent owner | Sep 29, 2025 | AWARD | 59,334 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President, CEO and Interim CFO | Apr 24, 2025 | TAX W/H | 27 | $1.24 | $33.48 | Form 4 |
| Fortress Biotech, Inc. | 10 percent owner | Mar 31, 2025 | AWARD | 67,806 | — | — | Form 4 |
| Fortress Biotech, Inc. | 10 percent owner | Dec 31, 2024 | OTHER | 0 | — | — | Form 4 |
| Jin David | director | Oct 23, 2024 | OTHER | 0 | — | — | Form 4 |
| Fortress Biotech, Inc. | 10 percent owner | Jun 27, 2024 | AWARD | 575,191 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | May 31, 2024 | TAX W/H | 1,396 | $0.35 | $488.60 | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Apr 24, 2022 | TAX W/H | 1,248 | $12.15 | $15.2K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Apr 24, 2023 | TAX W/H | 1,572 | $4.21 | $6.6K | Form 4 |
| MURPHY JAMES B | officer | Jan 19, 2024 | OTHER | 0 | — | — | Form 4 |
| Fortress Biotech, Inc. | 10 percent owner | Jan 2, 2024 | AWARD | 419,092 | — | — | Form 4 |
| Carney Peter | See Remarks | Dec 11, 2023 | DISPOSED | 0 | — | — | Form 4 |
| ZELEFSKY MICHAEL J | director | Jul 5, 2023 | AWARD | 7,246 | — | — | Form 4 |
| Chill Adam J. | director | Jul 5, 2023 | AWARD | 7,246 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director | Jul 5, 2023 | AWARD | 7,246 | — | — | Form 4 |
| WEISS MICHAEL S | director | Jul 5, 2023 | AWARD | 7,246 | — | — | Form 4 |
| Herskowitz Neil | director | Jul 5, 2023 | AWARD | 7,246 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Apr 24, 2023 | AWARD | 5,000 | — | — | Form 4 |
| WEISS MICHAEL S | director | Sep 26, 2016 | DISPOSED | 500,000 | $0.15 | $73.5K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Sep 26, 2016 | DISPOSED | 500,000 | $0.15 | $73.5K | Form 4 |
| Litchman Manuel MD | director | Sep 13, 2022 | BUY | 5,000 | $0.52 | $2.6K | Form 4 |
| Litchman Manuel MD | director | Jun 21, 2022 | AWARD | 61,000 | — | — | Form 4 |
| Litchman Manuel MD | director | Mar 18, 2022 | BUY | 5,000 | $0.74 | $3.7K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Sep 13, 2022 | BUY | 5,000 | $0.52 | $2.6K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Jul 29, 2022 | AWARD | 71,664 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director | Mar 18, 2022 | BUY | 4,094 | $0.74 | $3.0K | Form 4 |
| Herskowitz Neil | director | Jul 29, 2022 | AWARD | 71,664 | — | — | Form 4 |
| ZELEFSKY MICHAEL J | director | Jul 29, 2022 | AWARD | 71,664 | — | — | Form 4 |
| Chill Adam J. | director | Jul 29, 2022 | AWARD | 71,664 | — | — | Form 4 |
| WEISS MICHAEL S | director | Jul 29, 2022 | AWARD | 71,664 | — | — | Form 4 |
| Fortress Biotech, Inc. | director | Jan 6, 2023 | AWARD | 2,807,008 | — | — | Form 4 |
| Lurier Eliot M | Interim CFO | Apr 18, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Dec 8, 2021 | AWARD | 22,500 | — | — | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Dec 14, 2021 | SELL | 4,374 | $1.83 | $8.0K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Oct 27, 2021 | BUY | 65,000 | $2.24 | $145.6K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Oct 12, 2021 | SELL | 4,450 | $2.28 | $10.1K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Aug 31, 2021 | AWARD | 1,170 | $2.58 | $3.0K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Aug 31, 2021 | AWARD | 2,746 | $2.58 | $7.1K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Jul 30, 2021 | BUY | 86,206 | $2.91 | $250.9K | Form 4 |
| ZELEFSKY MICHAEL J | director | Jun 28, 2021 | AWARD | 13,774 | — | — | Form 4 |
| WEISS MICHAEL S | director | Jun 28, 2021 | AWARD | 13,774 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director | Jun 28, 2021 | AWARD | 13,774 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Jun 17, 2021 | AWARD | 61,000 | — | — | Form 4 |
| Herskowitz Neil | director | Jun 28, 2021 | AWARD | 13,774 | — | — | Form 4 |
| Chill Adam J. | director | Jun 28, 2021 | AWARD | 13,774 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | May 22, 2020 | SELL | 4,025 | $3.04 | $12.2K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | May 22, 2020 | SELL | 8,348 | $3.04 | $25.4K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Dec 6, 2019 | SELL | 6,144 | $3.69 | $22.7K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Mar 31, 2020 | SELL | 3,033 | $2.64 | $8.0K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | May 22, 2020 | SELL | 880 | $3.04 | $2.7K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Oct 21, 2020 | SELL | 3,056 | $2.97 | $9.1K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Dec 8, 2020 | SELL | 5,185 | $3.03 | $15.7K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Apr 9, 2021 | SELL | 2,423 | $3.36 | $8.1K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Mar 5, 2021 | BUY | 165,562 | $3.12 | $516.6K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Feb 26, 2021 | AWARD | 5,000 | $2.83 | $14.2K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Feb 26, 2021 | AWARD | 1,043 | $2.83 | $3.0K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Dec 15, 2020 | AWARD | 22,500 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director | Dec 14, 2020 | BUY | 100,000 | $2.66 | $266.0K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Aug 31, 2020 | AWARD | 1,182 | $2.48 | $2.9K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Jul 14, 2020 | AWARD | 16,611 | $2.48 | $41.2K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Feb 28, 2020 | AWARD | 831 | $2.48 | $2.1K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Dec 15, 2020 | BUY | 100,000 | $2.91 | $291.0K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Sep 15, 2020 | AWARD | 61,000 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Aug 31, 2020 | AWARD | 5,000 | $2.48 | $12.4K | Form 4 |
| ROSENWALD LINDSAY A MD | director | Dec 14, 2020 | BUY | 100,000 | $2.66 | $266.0K | Form 4 |
| ZELEFSKY MICHAEL J | director | Jul 14, 2020 | AWARD | 16,611 | — | — | Form 4 |
| WEISS MICHAEL S | director | Jul 14, 2020 | AWARD | 16,611 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director | Jul 14, 2020 | AWARD | 16,611 | — | — | Form 4 |
| Herskowitz Neil | director | Jul 14, 2020 | AWARD | 16,611 | — | — | Form 4 |
| Chill Adam J. | director | Jul 14, 2020 | AWARD | 16,611 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Jun 11, 2020 | BUY | 153,846 | $3.25 | $500.0K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | May 21, 2020 | BUY | 90,000 | $3.13 | $281.7K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | May 14, 2020 | BUY | 90,000 | $2.79 | $251.1K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Mar 26, 2020 | AWARD | 122,000 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Mar 5, 2020 | AWARD | 5,000 | $2.48 | $12.4K | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Mar 26, 2020 | AWARD | 36,250 | — | — | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Mar 5, 2020 | AWARD | 524 | $2.48 | $1.3K | Form 4 |
| ZELEFSKY MICHAEL J | director | Jun 7, 2017 | DISPOSED | 0 | — | — | Form 4 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | Apr 16, 2019 | AWARD | 35,000 | — | — | Form 4 |
| Herskowitz Neil | director | Aug 28, 2019 | AWARD | 13,812 | — | — | Form 4 |
| Chill Adam J. | director | Aug 28, 2019 | AWARD | 13,812 | — | — | Form 4 |
| WEISS MICHAEL S | director | Aug 28, 2019 | AWARD | 13,812 | — | — | Form 4 |
| WEISS MICHAEL S | director | Jun 14, 2018 | AWARD | 10,000 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director | Aug 28, 2019 | AWARD | 13,812 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director | Jun 14, 2018 | AWARD | 10,000 | — | — | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Dec 10, 2018 | BUY | 8,000 | $3.35 | $26.8K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Dec 4, 2018 | BUY | 7,500 | $3.60 | $27.0K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Nov 26, 2018 | BUY | 5,000 | $3.87 | $19.4K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Nov 21, 2018 | BUY | 5,000 | $4.21 | $21.0K | Form 4 |
| Litchman Manuel MD | director, officer: President and CEO | Nov 20, 2018 | BUY | 2,500 | $3.89 | $9.7K | Form 4 |
| Herskowitz Neil | director | Nov 23, 2018 | BUY | 1,000 | $3.96 | $4.0K | Form 4 |
| Herskowitz Neil | director | Jun 14, 2018 | AWARD | 10,000 | — | — | Form 4 |
| Achenbach Brian | VP, Fin. & Corp. Controller | Nov 20, 2018 | BUY | 500 | $3.87 | $1.9K | Form 4 |
| Achenbach Brian | VP, Fin. & Corp. Controller | Nov 19, 2018 | BUY | 1,000 | $4.25 | $4.3K | Form 4 |
| Achenbach Brian | VP, Fin. & Corp. Controller | Nov 16, 2018 | BUY | 1,000 | $4.31 | $4.3K | Form 4 |